Results 201 to 210 of about 9,770,479 (402)
Interplay between RNA‐protein interactions and RNA structures in gene regulation
Methodological advances in mapping transcriptome‐wide RNA‐protein interactions and RNA structures have started to uncover the potential of RNP conformations in gene regulation. Competing RNA–RNA, RNA‐protein and protein–protein interactions shape the compaction and function of RNPs throughout their lifetime and may provide novel therapeutic targets in ...
Jenni Rapakko +2 more
wiley +1 more source
Rucaparib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome. [PDF]
Ludlow S, Shariff B, Syed M.
europepmc +1 more source
Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions: CSM's reply [PDF]
Ronald D. Mann
openalex +1 more source
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel +9 more
wiley +1 more source
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) caused by niraparib: a novel antineoplastic agent. [PDF]
Vázquez-Barrera I +4 more
europepmc +1 more source
Detection of Serum IgE Antibodies that React with Alcuronium and Tubocurarine after Lifethreatening Reactions to Muscle-relaxant Drugs [PDF]
Brian A. Baldo, M. McD. Fisher
openalex +1 more source
Rieder, Michael, Ferro, Albert
openaire +3 more sources
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee +3 more
wiley +1 more source
Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone
Karissa Libson, BA +3 more
doaj +1 more source
An e-Reporting Tool for Facilitating Submission of Veterinary Adverse Drug Reaction Reports. [PDF]
Davies H +6 more
europepmc +1 more source

